These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 38254674)
1. The Use of Schisandrin B to Combat Triple-Negative Breast Cancers by Inhibiting NLRP3-Induced Interleukin-1β Production. Chang CM; Liang TR; Lam HYP Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254674 [TBL] [Abstract][Full Text] [Related]
2. Comparative effects of schisandrin A, B, and C on Propionibacterium acnes-induced, NLRP3 inflammasome activation-mediated IL-1β secretion and pyroptosis. Guo M; An F; Yu H; Wei X; Hong M; Lu Y Biomed Pharmacother; 2017 Dec; 96():129-136. PubMed ID: 28972885 [TBL] [Abstract][Full Text] [Related]
3. Schisandrin B exhibits potent anticancer activity in triple negative breast cancer by inhibiting STAT3. Dai X; Yin C; Guo G; Zhang Y; Zhao C; Qian J; Wang O; Zhang X; Liang G Toxicol Appl Pharmacol; 2018 Nov; 358():110-119. PubMed ID: 30195018 [TBL] [Abstract][Full Text] [Related]
4. Thymoquinone, a Novel Multi-Strike Inhibitor of Pro-Tumorigenic Breast Cancer (BC) Markers: CALR, NLRP3 Pathway and sPD-L1 in PBMCs of HR+ and TNBC Patients. Elgohary S; Eissa RA; El Tayebi HM Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762557 [TBL] [Abstract][Full Text] [Related]
5. Berberine inhibits NLRP3 Inflammasome pathway in human triple-negative breast cancer MDA-MB-231 cell. Yao M; Fan X; Yuan B; Takagi N; Liu S; Han X; Ren J; Liu J BMC Complement Altern Med; 2019 Aug; 19(1):216. PubMed ID: 31412862 [TBL] [Abstract][Full Text] [Related]
6. Schisandrin B Inhibits NLRP3 Inflammasome Pathway and Attenuates Early Brain Injury in Rats of Subarachnoid Hemorrhage. Chen S; Ding YH; Shi SS; Tu XK Chin J Integr Med; 2022 Jul; 28(7):594-602. PubMed ID: 35015222 [TBL] [Abstract][Full Text] [Related]
7. Schisandrin improves lipopolysaccharide-induced acute lung injury by inhibiting the inflammatory response in vivo and in vitro. Li W; Huang Q; Yu J; Yang Y; Yu J; Liu Y; Song H; Cui L; Niu X J Food Biochem; 2022 Jul; 46(7):e14141. PubMed ID: 35313003 [TBL] [Abstract][Full Text] [Related]
8. NLRP3 augmented resistance to gemcitabine in triple-negative breast cancer cells via EMT/IL-1β/Wnt/β-catenin signaling pathway. Zheng Q; Yao D; Cai Y; Zhou T Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32578856 [TBL] [Abstract][Full Text] [Related]
9. Schisandrin B induces an Nrf2-mediated thioredoxin expression and suppresses the activation of inflammasome in vitro and in vivo. Leong PK; Ko KM Biofactors; 2015; 41(5):314-23. PubMed ID: 26307448 [TBL] [Abstract][Full Text] [Related]
10. Network pharmacology for systematic understanding of Schisandrin B reduces the epithelial cells injury of colitis through regulating pyroptosis by AMPK/Nrf2/NLRP3 inflammasome. Zhang W; Wang W; Shen C; Wang X; Pu Z; Yin Q Aging (Albany NY); 2021 Oct; 13(19):23193-23209. PubMed ID: 34628369 [TBL] [Abstract][Full Text] [Related]
11. Schisandrin C: an active compound from the fruit of Schisandra chinensis in anti-inflammation and anti-oxidation. Kim TW; Hwang S; Park MS; Kim HK; Park MH Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(15):167-173. PubMed ID: 38279455 [TBL] [Abstract][Full Text] [Related]
12. [Inhibitory effect and mechanism of deoxyschizandrin on NLRP3 inflammasome]. Cui HR; Li PY; Li YM; Wang RL; He JJ; Sang XX; Cai GM; Niu M; Wang JB; Bai ZF; Xiao XH Yao Xue Xue Bao; 2017 Jan; 52(1):80-5. PubMed ID: 29911779 [TBL] [Abstract][Full Text] [Related]
13. Schisandrin A inhibits triple negative breast cancer cells by regulating Wnt/ER stress signaling pathway. Xu X; Rajamanicham V; Xu S; Liu Z; Yan T; Liang G; Guo G; Zhou H; Wang Y Biomed Pharmacother; 2019 Jul; 115():108922. PubMed ID: 31048190 [TBL] [Abstract][Full Text] [Related]
14. Inflammasome activation in peritumoral astrocytes is a key player in breast cancer brain metastasis development. Mészáros Á; Molnár K; Fazakas C; Nógrádi B; Lüvi A; Dudás T; Tiszlavicz L; Farkas AE; Krizbai IA; Wilhelm I Acta Neuropathol Commun; 2023 Sep; 11(1):155. PubMed ID: 37749707 [TBL] [Abstract][Full Text] [Related]
15. Schisandrin B inhibits cell proliferation and induces apoptosis in human cholangiocarcinoma cells. Yang X; Wang S; Mu Y; Zheng Y Oncol Rep; 2016 Oct; 36(4):1799-806. PubMed ID: 27499090 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of NLRP3 inflammasome contributes to paclitaxel efficacy in triple negative breast cancer treatment. Balahura Stămat LR; Dinescu S Sci Rep; 2024 Oct; 14(1):24753. PubMed ID: 39433537 [TBL] [Abstract][Full Text] [Related]
17. Schisandrin B attenuates cancer invasion and metastasis via inhibiting epithelial-mesenchymal transition. Liu Z; Zhang B; Liu K; Ding Z; Hu X PLoS One; 2012; 7(7):e40480. PubMed ID: 22848381 [TBL] [Abstract][Full Text] [Related]
18. Coenzyme Q Yang HL; Lin PY; Vadivalagan C; Lin YA; Lin KY; Hseu YC Arch Toxicol; 2023 Apr; 97(4):1047-1068. PubMed ID: 36847822 [TBL] [Abstract][Full Text] [Related]
19. Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer. Liubomirski Y; Lerrer S; Meshel T; Morein D; Rubinstein-Achiasaf L; Sprinzak D; Wiemann S; Körner C; Ehrlich M; Ben-Baruch A Front Immunol; 2019; 10():804. PubMed ID: 31105691 [TBL] [Abstract][Full Text] [Related]
20. Tumor-Stroma-Inflammation Networks Promote Pro-metastatic Chemokines and Aggressiveness Characteristics in Triple-Negative Breast Cancer. Liubomirski Y; Lerrer S; Meshel T; Rubinstein-Achiasaf L; Morein D; Wiemann S; Körner C; Ben-Baruch A Front Immunol; 2019; 10():757. PubMed ID: 31031757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]